[PRLD] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[PRLD] Prelude Therapeutics Incorporated
Announcement Date
15-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 28.88%
YoY- 36.10%
Quarter Report
PRLD's Result
PRLD's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -30,608 -30,431 -27,718 -28,641 -29,958 -27,374 -29,465 2.56%
Tax -279 239 -1,397 -7,654 -448 -2,087 -823 -51.34%
NP -30,608 -30,431 -26,321 -20,987 -29,510 -25,287 -28,642 4.52%
Tax Rate - - - - - - - -
Total Cost 30,608 30,431 26,321 20,987 29,510 25,287 28,642 4.52%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.45 -0.54 -0.55 -0.44 -0.62 -0.53 -0.61 -18.34%
EPS Diluted -0.45 -0.54 -0.55 -0.44 -0.62 -0.53 -0.61 -18.34%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.